MarketPeel
Insider Trading Intelligence
EVP R&D, Chief Medical Officer
Thu, Dec 5, 2024
Dec 5
sold $290.46k of ALKS
9,221 shares @ $31.50
Decreased holdings by -13.40%
30th largest trade (out of 157)
Planned (10b5-1)
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 17% above 200-day moving average
ALKSAlkermes plc.
Health CarePharmaceuticals
1D0.00%
1W-1.49%
1M-8.62%
3M
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback